Core One Labs announces a research breakthrough to help improve consistency in psilocybin dosing.
Articles
Michigan Prosecutor Won’t Pursue Most Marijuana Or Psychedelics Cases, ‘Regardless Of The Amount’
A county prosecutor in Michigan announced on Tuesday that his office will not be pursuing charges over possessing marijuana or entheogenic substances like psilocybin and ayahuasca — “regardless of the amount at issue.”
Minerco Inc the Magic Mushroom Company Appoints Health Care Consultant Paul Hoonjan as President
Oakland, California--(Newsfile Corp. - January 11, 2021) - The Magic Mushroom Company (OTCP Pink: MINE) specializing in growing, research, production and distribution of psilocybin mushrooms, announced today that Paul Hoonjan has been appointed as its new President.
KCSA Strategic Communications to Host Inaugural KCSA Psychedelics Investor Conference on January 26-27, 2021
KCSA Communications hosts an investment conference featuring Rick Doblin (MAPS) as a keynote speaker.
New York Governor Calls For Marijuana Legalization In State Of The State Address
New York Gov. Andrew Cuomo (D) on Monday again discussed the need to legalize marijuana in 2021.
Airdrie cancer patient first Albertan to undergo legal magic mushroom therapy
Tony White called his therapy session powered by magic mushrooms “a good trip.”
Connecticut Gov. Calls for Cannabis Legalization
In his State of the State address on Wednesday, Connecticut Gov. Ned Lamont (D) said he planned to work to legalize cannabis in the coming session.
Will ATAI IPO Be The First Major Psychedelics Catalyst For 2021?
The ATAI Life Sciences IPO could come as soon as the end of January. What does this mean for psychedelic stock investors?
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand
MindMed closes on a CAD$92.1 million financing from what was originally a $50 million offering. Total cash on hand increases to US$144.4 million.
Will psychedelic mushroom vacations come to the U. S.?
The palm-fringed beachfront and breezy cabanas at MycoMeditations are the stuff of glossy travel brochures, but the barefoot vacationers roaming the Jamaican retreat center this winter are seeking a different kind of trip entirely.
Further Research into Psilocybin Opens New Doors for Treatment
NEW YORK, Jan. 7, 2021 /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others.
BetterLife Pharma forms psychedelic research advisory board and taps industry veteran Hattie Wells as its first member
BetterLife Pharma Inc tapped the experience of psychedelic pioneer Hattie Wells to join its new psychedelic research advisory board.
Mind Cure Tackles Mental Health Crisis On Two Fronts
Psychedelic Stock Watch connects the dots regarding Mind Cure's clinic launch and latest product development news.
Mind Cure Announces Build-Out of Digital Therapeutics,iSTRYM: A Technology Platform for Mental Wellness Optimization & PsychedelicResearch
Mind Cure's iSTRYM digital therapeutics platform is designed to provide real-time data regarding patient care.
Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products
Numinus announces a product development agreement with Optimi Health Corp.